INTRODUCTION: Visceral leishmaniasis (VL) is among the seven global endemic diseases assigned a high priority by the World Health Organization. In Latin America, most cases occur in Brazil. Despite the availability of intensive treatment resources and protocols for specific treatment, lethality rates for VL have increased in several regions in the country over the past 10 years, particularly in patients under one and over 50 years of age. As the growth of the elderly population accelerates in Brazil, VL poses a greater challenge to public health. Given the scarcity of studies addressing the disease in this age group, the purpose of this study was to identify factors associated with VL lethality among the elderly. METHODS/KEY FINDINGS: This analytical, cross-sectional epidemiological study comprised 80 elderly patients who sought treatment at the teaching hospital of the Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil, in the period 2000-2013.Clinical, laboratory and treatment variables were investigated from records of elderly patients with VL diagnosis confirmed by at least one laboratory test positive (culture for parasite or direct parasitological examination; reactive immunofluorescence; immunochromatographic test with recombinant antigens) or patients without laboratory confirmation who lived in endemic areas and responded favorably to therapeutic trial, as defined by the Brazilian Ministry of Health. Of the 80 patients included, 78 tested positive to at least one exam; in two cases, diagnosis was based on clinical and epidemiological criteria. The lethality rate was 20%. Multivariate analysis revealed an association between death and time elapsed from symptom onset.
INTRODUCTION:Visceral leishmaniasis (VL) is among the seven global endemic diseases assigned a high priority by the World Health Organization. In Latin America, most cases occur in Brazil. Despite the availability of intensive treatment resources and protocols for specific treatment, lethality rates for VL have increased in several regions in the country over the past 10 years, particularly in patients under one and over 50 years of age. As the growth of the elderly population accelerates in Brazil, VL poses a greater challenge to public health. Given the scarcity of studies addressing the disease in this age group, the purpose of this study was to identify factors associated with VL lethality among the elderly. METHODS/KEY FINDINGS: This analytical, cross-sectional epidemiological study comprised 80 elderly patients who sought treatment at the teaching hospital of the Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil, in the period 2000-2013.Clinical, laboratory and treatment variables were investigated from records of elderly patients with VL diagnosis confirmed by at least one laboratory test positive (culture for parasite or direct parasitological examination; reactive immunofluorescence; immunochromatographic test with recombinant antigens) or patients without laboratory confirmation who lived in endemic areas and responded favorably to therapeutic trial, as defined by the Brazilian Ministry of Health. Of the 80 patients included, 78 tested positive to at least one exam; in two cases, diagnosis was based on clinical and epidemiological criteria. The lethality rate was 20%. Multivariate analysis revealed an association between death and time elapsed from symptom onset.
Authors: Ana Nilce Silveira Maia-Elkhoury; Waneska A Alves; Márcia Leite de Sousa-Gomes; Joana Martins de Sena; Expedito A Luna Journal: Cad Saude Publica Date: 2008-12 Impact factor: 1.632
Authors: José Angelo Lindoso; Gláucia Fernandes Cota; Alda Maria da Cruz; Hiro Goto; Ana Nilce Silveira Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Márcia Leite de Sousa-Gomes; Joanna Reis Santos-Oliveira; Ana Rabello Journal: PLoS Negl Trop Dis Date: 2014-09-18
Authors: Francisco Rogerlândio Martins-Melo; Mauricélia da Silveira Lima; Alberto Novaes Ramos; Carlos Henrique Alencar; Jorg Heukelbach Journal: PLoS One Date: 2014-04-03 Impact factor: 3.240
Authors: Sam Lyvannak; Korb Sreynich; Sing Heng; Miliya Thyl; Arjun Chandna; Ngoun Chanpheaktra; Ngeth Pises; Prak Farrilend; Jason Jarzembowski; Vasiliki Leventaki; Jonathan Davick; Cindy Neunert; Frank Keller; Leslie S Kean; Bruce Camitta; Katherine Tarlock; Benjamin Watkins Journal: Am J Trop Med Hyg Date: 2022-06-13 Impact factor: 3.707
Authors: João Gabriel Guimarães Luz; Danilo Bueno Naves; Amanda Gabriela de Carvalho; Gilvani Alves Meira; João Victor Leite Dias; Cor Jesus Fernandes Fontes Journal: Rev Inst Med Trop Sao Paulo Date: 2018-03-08 Impact factor: 1.846
Authors: João Gabriel Guimarães Luz; Amanda Gabriela de Carvalho; Danilo Bueno Naves; João Victor Leite Dias; Cor Jesus Fernandes Fontes Journal: Mem Inst Oswaldo Cruz Date: 2019-10-28 Impact factor: 2.743
Authors: Ana Nilce S Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Samantha Y O B Valadas; Marcia L Sousa-Gomes; José Angelo Lauletta Lindoso; Elisa Cupolillo; Jose Antonio Ruiz-Postigo; Daniel Argaw; Manuel J Sanchez-Vazquez Journal: PLoS Negl Trop Dis Date: 2019-12-19
Authors: Caique J N Ribeiro; Allan D Dos Santos; Shirley V M A Lima; Eliete R da Silva; Bianca V S Ribeiro; Andrezza M Duque; Marcus V S Peixoto; Priscila L Dos Santos; Iris M de Oliveira; Michael W Lipscomb; Karina C G M de Araújo; Tatiana R de Moura Journal: PLoS Negl Trop Dis Date: 2021-01-19